共 161 条
[1]
Potschka H(2010)Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies? Epilepsia 51 1333-1347
[2]
Ishiwata K(2007) evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically J Nucl Med 48 81-87
[3]
Kawamura K(2008)[ J Cereb Blood Flow Metab 28 207-216
[4]
Yanai K(2001)C]Flumazenil PET in temporal lobe epilepsy: do we need an arterial input function or kinetic modeling? Neurology 56 1650-1658
[5]
Hendrikse NH(1996)Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome J Clin Invest 97 2517-2524
[6]
Hammers A(1998)P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs Br J Pharmacol 124 416-424
[7]
Panagoda P(1999)Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both Br J Pharmacol 128 403-411
[8]
Heckemann RA(2007) and Expert Rev Anticancer Ther 7 447-459
[9]
Kelsch W(2008) genes have been disrupted J Nucl Med 49 1328-1335
[10]
Turkheimer FE(2011)The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein BMC Med Imaging 11 1-89